
Viemed Healthcare, Inc.: updates and filings
Price
$8.78
November 18, 2026Market cap $339M
What Ploutos Investor adds for Viemed Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 4, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operations, Regulation FD disclosureForm8-K
- Sep 24, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Aug 20, 2026Regulation FD disclosureForm8-K
- Aug 5, 2026Shares registered for employeesFormS-8
- Aug 3, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 3, 2026Results of operationsForm8-K
- Jul 24, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 4, 2026Officer or director change, shareholder voteForm8-K
- Jun 2, 2026Regulation FD disclosureForm8-K
- May 5, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 5, 2026Results of operationsForm8-K
- Apr 22, 2026Annual meeting proxy statementFormDEF 14A
- Apr 22, 2026Additional annual meeting materialFormDEFA14A
- Apr 22, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Mar 16, 2026Regulation FD disclosureForm8-K
- Mar 4, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 4, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Nov 7, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 7, 2025Material agreement entered, Regulation FD disclosureForm8-K
- Nov 5, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Nov 5, 2025Results of operationsForm8-K
- Sep 23, 2025Regulation FD disclosure, other material eventsForm8-K
- Aug 12, 2025Shares registered for employeesFormS-8
- Aug 6, 2025Quarterly reportfor the period to Jun 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Sep 24, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Aug 20, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 5, 2026 | S-8 | Shares registered for employees | Document |
| Aug 3, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 3, 2026 | 8-K | Results of operations | Document |
| Jul 24, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 4, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| Jun 2, 2026 | 8-K | Regulation FD disclosure | Document |
| May 5, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 5, 2026 | 8-K | Results of operations | Document |
| Apr 22, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 22, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 22, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Mar 16, 2026 | 8-K | Regulation FD disclosure | Document |
| Mar 4, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 4, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Nov 7, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 7, 2025 | 8-K | Material agreement entered, Regulation FD disclosure | Document |
| Nov 5, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Nov 5, 2025 | 8-K | Results of operations | Document |
| Sep 23, 2025 | 8-K | Regulation FD disclosure, other material events | Document |
| Aug 12, 2025 | S-8 | Shares registered for employees | Document |
| Aug 6, 2025 | 10-Q | Quarterly reportfor the period to Jun 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 1, 2018.
The full analysis
What do Viemed Healthcare's filings show?
The filings are where every one of Viemed Healthcare's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.